Literature DB >> 32258518

The prevalence of diabetes and metabolic syndrome and associated risk factors in Sudanese individuals with gallstones: a cross sectional survey.

Ahmed Omer Almobarak1, Ayat Jervase2, Aza Abdelrahman Fadl2, Nur Ibrahim Ali Garelnabi3, Suzan Al Hakem4, Tarig Mohamed Hussein3, Amro Ahmad Aljack Ahmad5, Inas Salah El-den Ahmed6, Safaa Badi7, Mohamed H Ahmed8.   

Abstract

BACKGROUND: The gallstones are common health problem across the world with huge financial burden on health authorities. Obesity and insulin resistance are associated with risk of gallstones disease (GSD). The aim of this study was to assess the prevalence of metabolic syndrome (MetS) and diabetes and associated risk factors in Sudanese patients with gallstones.
METHODS: A prospective cross-sectional study, enrolled patients with gallstones attending Ibn Sina Specialized Teaching Hospital for gastrointestinal and hepatobiliary diseases. A structured questionnaire was applied, anthropometric measures were taken, and blood tested for HbA1c, fasting glucose and lipid profile. Data was analysed using SPSS version 23.
RESULTS: A total number of 151 participants were recruited in the study, 71 of them were ultrasound confirmed GSD patients, and the other 80 were controls without GSD over a period of six months. The prevalence of the MetS and diabetes was 30% and 23.9% respectively. Borderline diabetes was 16.9% and overweight and obesity constituted more than half of the sample 59.6%. Using Chi-Square test, a statistically significant association was found between MetS and HDL, TG, LDL level, waist circumference and blood pressure (BP). Absolute predictors and the risk factors for gallstone disease were waist circumference, age, HbA1c and LDL.
CONCLUSIONS: The prevalence of MetS and diabetes among gallstone patients was 30% and 23.9% respectively. Absolute predictors and the risk factors for gallstone disease were waist circumference, age, HbA1c and LDL. 2020 Translational Gastroenterology and Hepatology. All rights reserved.

Entities:  

Keywords:  Gallstones; Sudan; diabetes; metabolic syndrome (MetS); obesity

Year:  2020        PMID: 32258518      PMCID: PMC7063511          DOI: 10.21037/tgh.2019.10.09

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN: 2415-1289


  22 in total

Review 1.  Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.

Authors:  Scott M Grundy; H Bryan Brewer; James I Cleeman; Sidney C Smith; Claude Lenfant
Journal:  Circulation       Date:  2004-01-27       Impact factor: 29.690

Review 2.  The burden of gallstone disease in Europe.

Authors:  R Aerts; F Penninckx
Journal:  Aliment Pharmacol Ther       Date:  2003-11       Impact factor: 8.171

3.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

4.  Association of obesity and type II diabetes mellitus as a risk factor for gallstones.

Authors:  M Pacchioni; C Nicoletti; M Caminiti; G Calori; V Curci; R Camisasca; A E Pontiroli
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

Review 5.  Cholelithiasis and cholecystitis.

Authors:  Bruce D Schirmer; Kathryne L Winters; Richard F Edlich
Journal:  J Long Term Eff Med Implants       Date:  2005

6.  A comparison of the prevalence of the metabolic syndrome using two proposed definitions.

Authors:  Earl S Ford; Wayne H Giles
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

7.  Hepatic insulin resistance directly promotes formation of cholesterol gallstones.

Authors:  Sudha B Biddinger; Joel T Haas; Bian B Yu; Olivier Bezy; Enxuan Jing; Wenwei Zhang; Terry G Unterman; Martin C Carey; C Ronald Kahn
Journal:  Nat Med       Date:  2008-06-29       Impact factor: 53.440

8.  Ultrasound prevalence of gallstone disease in diabetic patients at Ibadan, Nigeria.

Authors:  A M Agunloye; A M Adebakin; J O Adeleye; A O Ogunseyinde
Journal:  Niger J Clin Pract       Date:  2013 Jan-Mar       Impact factor: 0.968

9.  Hepatitis C virus infection is a risk factor for gallstone disease: a prospective hospital-based study of patients with chronic viral C hepatitis.

Authors:  M Acalovschi; C Buzas; C Radu; M Grigorescu
Journal:  J Viral Hepat       Date:  2009-05-26       Impact factor: 3.728

Review 10.  Prevalence of Metabolic Syndrome among Iranian Population: A Systematic Review and Meta-analysis.

Authors:  Sahar Dalvand; Seyed Hassan Niksima; Reza Meshkani; Reza Ghanei Gheshlagh; Sahar Sadegh-Nejadi; Wesam Kooti; Naser Parizad; Hossein Zahednezhad; Reza Afrisham
Journal:  Iran J Public Health       Date:  2017-04       Impact factor: 1.429

View more
  2 in total

1.  The positive effect of short-term nano-curcumin therapy on insulin resistance and serum levels of afamin in patients with metabolic syndrome.

Authors:  Nejat Kheiripour; Zahra Khodamoradi; Akram Ranjbar; Shiva Borzouei
Journal:  Avicenna J Phytomed       Date:  2021 Mar-Apr

2.  Prevalence and Risk Factors of Gallbladder Stones and Polyps in Liaoning, China.

Authors:  Xinhe Zhang; Lin Guan; Haoyu Tian; Yiling Li
Journal:  Front Med (Lausanne)       Date:  2022-04-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.